Anavex Life Sciences Corp (AVXL)

[Investor2014]

Here are the facts again.

While fiscal 2020 was marked by the outbreak of COVID-19, which temporarily slowed down activities in many of the countries in which these trials are taking place, our clinical trials were able to continue largely uninterrupted in compliance with local regulations and policies, and we were able to continue to recruit and screen new patients as much as possible to advance these studies. Additionally, we commenced the first in human Phase 1 clinical trial of ANAVEX®3-71 during fiscal 2020 with focus on the treatment of Frontotemporal Dementia (FTD) and other dementia indications with unmet medical need.

I suppose largely uninterrupted and as much as possible by Anavex definitions is about 17% of intentions using same methodology as for quantifying catalyst milestone timings such as: Soon, around the corner, H1, H2, mid-year etc.